Mtar Technologies Limited (MTARTECH)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 revenue INR406.8 Cr (+200% y-y); EBITDA INR99.2 Cr (+483.3% y-y), margin 24.4%
- H2 FY27 expected stronger than H1; robust order book INR4,102 Cr in H1 FY27
- Capex INR500 Cr planned over 2 years; 75% debt funded, 25% internal accruals
- Civil nuclear order book INR820 Cr; major revenue ramp from FY28
- Fuel cells capacity expansion Phase 2 by Nov 2026, Phase 3 by Jun 2028
- Aerospace revenue target INR150 Cr in FY27; multiple customer qualifications ongoing
- Data center vertical potential INR350-450 Cr over 2 years; facility by Mar 2027
- Oil & gas facility operational by Nov 2026; production ramp from FY28
- Working capital days improved to 50 in Sep 2026; target 100 by FY27 end, 150 long-term
- Multiple analyst queries on working capital sustainability; management confident on targets
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MTARTECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MTARTECH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Mtar Technologies Limited
Important.
The summary above is generated automatically from Mtar Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.